Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Privigen Market Growth Potential: How Will Market Size Shift Through 2030?
The growth observed over the historical period stems from the expansion of plasma donation networks, a greater detection of primary immunodeficiency disorders, the availability of plasma-derived therapies, enhanced clinical guidelines for IVIG application, and the development of hospital-based infusion services.
The anticipated market expansion during the forecast period is fueled by the escalating demand for enduring immunotherapy treatments, the broadening reach of homecare infusion services, greater investment in securing plasma supplies, the rising incidence of autoimmune conditions, and enhanced manufacturing efficiency for IVIG products. Parallel to this, key developments expected in the forecast period include a surge in demand for immunoglobulin therapies, an expansion of the infrastructure for plasma collection, a growing preference for home-based IVIG administration, advancements in plasma fractionation technologies, and an increased emphasis on chronic immune disorders.
Get A Free Sample Report With In-Depth Market Insights:
Privigen Market Growth Drivers: What’s Behind The Acceleration?
The privigen market is set to expand due to the growing prevalence of immunodeficiency disorders, conditions that compromise the body’s immune system against infections and illnesses. This increase is attributed to factors such as enhanced awareness, improved diagnostic methods, longer lifespans for individuals with primary immunodeficiencies, greater use of immunosuppressive therapies, and higher instances of chronic diseases. Privigen, an intravenous immunoglobulin (IVIG), serves to manage these disorders by boosting antibody levels, thereby enabling patients to combat infections and maintain effective immune function. For example, the University of Oxford reported in May 2023 that the 19 most common autoimmune diseases affected 3-9% of the United Kingdom’s population in 2022, a figure that climbed to 10% in 2023. Consequently, the rising occurrence of immunodeficiency disorders is a significant driver for the privigen market. The privigen market is expected to advance with the increase in supportive government initiatives. These healthcare initiatives encompass government-implemented programs, policies, or actions designed to improve public health, enhance access to medical services, and foster the well-being of their citizens. The rise in such favorable initiatives stems from factors like the increasing demand for affordable and accessible medical care, the necessity to address aging populations and chronic illnesses, and ongoing advancements in medical technology. Government support for immunodeficiency treatments plays a crucial role by improving access to therapies like privigen, ensuring patients receive affordable and timely care through various funding and healthcare programs. For instance, in February 2023, the National Institute for Health and Care Research, a UK-based funding agency, disclosed that funding for the NIHR BioResource, which conducts research using genetic information for new tests and treatments for rare diseases including immunodeficiencies and hemophilia, was $50.89 million in 2022, escalating to $1005.17 million in 2023. Therefore, the growth in beneficial government initiatives is a key driver for the privigen market.
Privigen Market Segment Trends And Revenue Contributors
The privigen market covered in this report is segmented –
1) By Formulation: Liquid (10% solution), Lyophilized
2) By Indication: Primary Immunodeficiency (PI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immune Thrombocytopenic Purpura (ITP), Guillain-Barré Syndrome, Other Autoimmune Disorders
3) By End Users: Hospitals, Clinics, Homecare settings
Privigen Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the privigen market are CSL Behring AG
View The Full Privigen Market Report:
Privigen Market Top Region By Revenue And Market Share
North America was the largest region in the privigen market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the privigen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
